Stock Market News1 week InflaRx Stock Rises 8% on Conditional EC Nod for COVID-19 Drug Zacks
IFRX stock gains 8% on EC nod for Gohibic, under exceptional circumstances, to treat adult patients with COVID-19-induced ARDS.
XIFRX stock gains 8% on EC nod for Gohibic, under exceptional circumstances, to treat adult patients with COVID-19-induced ARDS.
X